Tenpointtx

Tenpointtx

Director/Senior Director, Regulatory Affairs

Remote (United States) · Director · Full-time

Sponsorship not specified$230k-$300kDetected 11 days ago
ComplianceProject ManagementExcelFDA RegulatoryPharmacovigilanceMicrosoft OfficeRegulatory Affairs

About the role

  • EEO Statement We are an Equal Opportunity Employer.
  • All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, national origin, disability, or protected veteran status.
  • If you need assistance and/or a reasonable accommodation due to a disability during the interview process, please place your accommodation request with your recruiting contact.

Responsibilities

  • This role collaborates cross-functionally to support product development, approval, and lifecycle management, ensuring alignment with global regulatory standards and business objectives.
  • Our lead investigational asset, YUVEZZI™, is designed to be the first and only combination therapy for presbyopia.
  • Reasonable accommodations may be made to enable individuals with disabilities to perform the essential functions of the role.

Requirements

  • Physical Requirements & ADA Statement This role is primarily a desk-based job requiring the ability to operate a computer and communicate effectively in a clinical work environment.
  • The employee may be required to sit for extended periods, engage in video or phone meetings, and use standard office equipment.

Nice to have

  • Veeva RIM would be considered a plus. · Proficiency with MS Office applications, especially Excel, Word, and PowerPoint.

Skills

  • Final pay determinations will depend on various factors, including but not limited to experience level, knowledge, skills, and abilities.

Compensation

  • $230k-$300k

Benefits

  • About Tenpoint Therapeutics Tenpoint Therapeutics is a global, commercial-ready biotechnology company focused on developing groundbreaking treatments to rejuvenate vision in the aging eye.
  • Its pipeline includes paradigm-shifting therapeutics for ophthalmic indications with significant unmet medical need, including presbyopia, cataracts, and geographic atrophy.

Company info

  • YUVEZZI™ is now approved in the US by the FDA, and we are actively working to submit YUVEZZI™ in several other markets.

Equal opportunity

  • EEO Statement We are an
  • Equal Opportunity Employer.
Apply directly at Tenpointtx →Create a free account for alerts like thisView Tenpointtx immigration profile

This listing is sourced directly from Tenpointtx's careers page and normalized into a canonical job model.